C.R. Bard Inc (BCR)

322.22
0.32 0.10
NYSE : Health Care
Prev Close 321.90
Open 321.38
Day Low/High 321.38 / 322.85
52 Wk Low/High 203.63 / 321.97
Volume 407.78K
Avg Volume 1.10M
Exchange NYSE
Shares Outstanding 72.57M
Market Cap 23.36B
EPS 7.20
P/E Ratio 40.95
Div & Yield 1.04 (0.30%)

Latest News

Bard Stock Sees Short Interest Fall 50.2%

The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 583,771 share decrease in total short interest for Bard Inc , to 579,444, a decrease of 50.19% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Deals of the Week: Waiting for Clarity

Deals of the Week: Waiting for Clarity

The week's action suggests other dealmakers may be thinking the same thing as Pfizer CEO Ian Read.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of C. R. Bard, Inc. To Becton, Dickinson And Company For $317 Per Share Is Fair To Shareholders - BCR

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased C.

Merger Buzz Drives Akorn to Top of Health Chart in April

Merger Buzz Drives Akorn to Top of Health Chart in April

Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.

Deals of the Week: Reason for Optimism

Deals of the Week: Reason for Optimism

Predictions that M&A would accelerate any day now might have started to come true.

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of C.

Good Medicine Makes for 3 Good Charts

Good Medicine Makes for 3 Good Charts

Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of C.

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Jim Cramer says a rally on French election results is fine, but don't forget great U.S. corporate earnings and merger activity.

French Election Fires Up Wall Street, Propels Stocks to Best Gains Since Early March

French Election Fires Up Wall Street, Propels Stocks to Best Gains Since Early March

A vote for the status quo lights a fire under European markets, which translates to a great day for Wall Street.

Cramer: Sorry, Popeye, but Market Rally Isn't Just About the French Connection

Cramer: Sorry, Popeye, but Market Rally Isn't Just About the French Connection

Let's play out what's allowing our markets to fly: Earnings.

Stocks Follow European Stocks Higher After French Election Brings Relief

Stocks Follow European Stocks Higher After French Election Brings Relief

Stocks enjoy their biggest gains since the beginning of March after centrist Emmanuel Macron wins the first round of the country's presidential elections over far-right Marine Le Pen.

Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

A bullish market and another quant upgrade could push BSX past our $31 target.

C. R. Bard, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger With Becton, Dickinson And Co.

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of C.

Jim Cramer on Becton Dickinson's Purchase of Bard

Jim Cramer on Becton Dickinson's Purchase of Bard

TheStreet's Jim Cramer weighs in on Becton Dickinson's BDX purchase of Bard BCR for $24 billion.

Dow Enjoys 200-Point Surge as Macron Win Provides Comfort to EU Worries

Dow Enjoys 200-Point Surge as Macron Win Provides Comfort to EU Worries

Stocks rocket higher on Monday after centrist Emmanuel Macron wins the first round of the country's presidential elections over far-right Marine Le Pen.

Becton Dickinson Announces $24 Billion Acquisition of C.R. Bard

Becton Dickinson Announces $24 Billion Acquisition of C.R. Bard

Bard was shopped to BD as an acquisition target about 15 years ago

Stock Futures Rally After Macron Wins First Round of French Election

Stock Futures Rally After Macron Wins First Round of French Election

Stock futures rocket higher on Monday after centrist Emmanuel Macron wins the first round of the country's presidential elections over far-right Marine Le Pen.

Becton Dickinson Acquires Medical Technology Peer C.R. Bard for Hefty Premium

Becton Dickinson Acquires Medical Technology Peer C.R. Bard for Hefty Premium

Bard shareholders will own 15% of the combined company.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

U.S. stock futures are set for solid gains and European stocks soar after the first round of France's elections put centrist Emmanuel Macron in the lead for the presidency.

Wake Up Wall Street: Centrist Emmanuel Macron in the Driver's Seat to Enter the Elysee Palace

Wake Up Wall Street: Centrist Emmanuel Macron in the Driver's Seat to Enter the Elysee Palace

Here are five things you must know for Monday, April 24.